
Ghana has formally opened two advanced scientific facilities aimed at improving the country’s health security and forensic services. President John Dramani Mahama led the inauguration of a Vaccine Research and Development (R&D) Laboratories complex and a Human Identification (DNA) Laboratory at the Noguchi Memorial Institute for Medical Research, located on the University of Ghana’s Legon campus.
The facilities were created in response to the August 6, 2025, military helicopter crash that claimed the lives of eight influential Ghanaians. Following the incident, Ghana lacked the necessary infrastructure to process DNA samples domestically, forcing officials to send tissue samples to South Africa for analysis. Families of the deceased faced prolonged delays in receiving identification results, exposing a significant shortfall in national forensic capabilities.
The Vaccine R&D Laboratories include specialized units such as an mRNA Expression Laboratory and a Protein Expression Laboratory. These will allow Ghanaian researchers to develop vaccines locally, reducing reliance on external suppliers—a lesson reinforced by the COVID-19 pandemic, when African nations often received vaccines later than wealthier regions.
The DNA Laboratory provides domestic infrastructure for human identification, forensic investigations, and paternity testing. President Mahama stated that the facility will eliminate the need to send samples abroad, ensuring faster and more dignified responses during national crises.
He expressed satisfaction that Ghana now possessed a world-class facility capable of strengthening both the nation’s forensic and public health systems.
Beyond emergency identification, the DNA Laboratory will assist in resolving paternity disputes, a frequent legal issue in Ghana. Mahama noted that while maternity is legally straightforward, paternity cases often require scientific verification, and the new facility will provide definitive answers for inheritance, child support, and custody matters.
Ghana’s investment in these facilities aligns with wider plans to develop its pharmaceutical sector. The government has allocated $1 billion under the Seventh Pillar of the New Economy Programme to establish pharmaceutical and biomanufacturing centers in the Eastern, Central, and Volta regions.
Health Minister Kwabena Mintah Akandoh called the new laboratories a key step toward creating a self-sufficient vaccine production system. He emphasized the importance of collaboration between the National Vaccine Institute, the Food and Drugs Authority, and research institutions to move from vaccine discovery to local manufacturing.
Mahama framed the facilities as part of a broader strategy to address recurring infectious disease threats in West Africa, including Mpox, Lassa fever, Ebola, and Marburg virus disease. He stressed that preparedness demands proactive investment in scientific capacity before outbreaks occur.
“Preparedness requires foresight, investment, and the courage to build capacity before a crisis strikes,” he stated.
Leave a Reply